Literature DB >> 15361646

Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy.

Christiaan P van Lingen1, Clark J Zeebregts, Jos J G M Gerritsen, H Jan Mulder, Walter J B Mastboom, Joost M Klaase.   

Abstract

BACKGROUND: At this moment, it is still debatable whether all patients with mobile rectal cancer who undergo surgical removal of the tumor should be treated with preoperative radiotherapy, since it is likely that only certain patients will benefit from this strategy. In this study, patients with mobile rectal cancer were immediately operated upon and only those with positive nodes or with incomplete resection received adjuvant radiotherapy. AIMS OF THE STUDY: To investigate the local recurrence rate after the use of a selective policy of adjuvant radiotherapy and to determine risk factors for local recurrence.
METHODS: In a 5-yr-period, 178 patients with rectal cancer were referred to our institute. A total of 131 patients with mobile rectal cancer were treated with curative intent, which implied a microscopically radical resection and no signs of distant metastasis at operation. A retrospective analysis was undertaken to investigate the incidence of local recurrence in this curative group and to determine risk factors for local recurrence.
RESULTS: The postoperative mortality in the curative group was 5.3%. Local recurrences were observed in 6 patients (4.6%) after a median period of 25 mo (range 11-37); two of them also had distant metastases detected at the same time. The highest local recurrence rates were seen in men (5.3%), in distal rectal cancers (6.9%), and in the node-positive group (8.7%).
CONCLUSION: A low local recurrence rate can be achieved after total mesorectal excision (TME) without preoperative radiotherapy. Our results suggest using preoperative radiotherapy only for those patients who are at a higher risk for local recurrence. Staging techniques for selection of these patients are at this moments till inappropriate.

Entities:  

Mesh:

Year:  2003        PMID: 15361646     DOI: 10.1385/IJGC:34:2-3:129

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  16 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Prospective evaluation of anorectal function after total mesorectal excision for rectal carcinoma with or without preoperative radiotherapy.

Authors:  P van Duijvendijk; J F M Slors; C W Taat; W F van Tets; G van Tienhoven; H Obertop; G E E Boeckxstaens
Journal:  Am J Gastroenterol       Date:  2002-09       Impact factor: 10.864

Review 3.  Methodology and reporting in studies of local recurrence after curative excision of the rectum for cancer.

Authors:  O F Dent; P H Chapuis; E L Bokey; R C Newland
Journal:  Br J Surg       Date:  2001-11       Impact factor: 6.939

4.  Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report.

Authors:  L Stocchi; H Nelson; D J Sargent; M J O'Connell; J E Tepper; J E Krook; R Beart
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

Review 5.  Locally recurrent rectal cancer.

Authors:  E Radice; R R Dozois
Journal:  Dig Surg       Date:  2001       Impact factor: 2.588

6.  Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery.

Authors:  R G Beets-Tan; G L Beets; R F Vliegen; A G Kessels; H Van Boven; A De Bruine; M F von Meyenfeldt; C G Baeten; J M van Engelshoven
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

7.  Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging.

Authors:  G Brown; A G Radcliffe; R G Newcombe; N S Dallimore; M W Bourne; G T Williams
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

8.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

9.  Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex.

Authors:  J A E Smith; P M King; R H S Lane; M R Thompson
Journal:  Br J Surg       Date:  2003-05       Impact factor: 6.939

10.  Total mesorectal excision in the operative treatment of carcinoma of the rectum.

Authors:  W E Enker; H T Thaler; M L Cranor; T Polyak
Journal:  J Am Coll Surg       Date:  1995-10       Impact factor: 6.113

View more
  5 in total

1.  A study on the usefulness of methylcellulose in rectal CT based on the analysis of the differences in absorption of radiation-permeable and radiation-impermeable materials.

Authors:  Jae-Hwan Cho; Hae-Kag Lee; Hyun-Ju Kim; Yeong-Cheol Heo; Jin-Hyeok Lee; In-Sik Hong
Journal:  Jpn J Radiol       Date:  2014-09-23       Impact factor: 2.374

2.  Can CRM Status on MRI Predict Survival in Rectal Cancers: Experience from the Indian Subcontinent.

Authors:  Mihir Chandarana; Supreeta Arya; Jean-Louis de Menezes; Reena Engineer; Vikas Ostwal; Prachi Patil; Suman Kumar; Rohit Dusane; Ashwin D'souza; Avanish Saklani
Journal:  Indian J Surg Oncol       Date:  2019-02-21

3.  Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study.

Authors: 
Journal:  BMJ       Date:  2006-09-19

Review 4.  [Preoperative imaging for colorectal cancer: surgeons' perspective].

Authors:  I Iesalnieks; A Agha
Journal:  Radiologe       Date:  2019-09       Impact factor: 0.635

5.  The quality of total mesorectal excision specimen: A review of its macroscopic assessment and prognostic significance.

Authors:  Shi-Bo Song; Guo-Ju Wu; Hong-Da Pan; Hua Yang; Mao-Lin Hu; Qiang Li; Qiu-Xia Yan; Gang Xiao
Journal:  Chronic Dis Transl Med       Date:  2018-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.